Sponsor Pipeline

Galderma R&D Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
15
Active Trials
8
Recruiting
4
Phase 3
2
Disease Areas
8
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-08-15 NCT07660835
Pharmacokinetics, Safety and Efficacy of Nemolizumab in Participants Aged 6 to 23 Months…
Recruitment opened
2026-08-15 NCT07566286
Study to Evaluate the Safety of Retreatment With Restylane® Lyft With Lidocaine for…
Recruitment opened
2026-08-14 NCT07344584
A Prospective Pilot Study to Evaluate Safety and Effectiveness of GP0122 and GP0124 for…
overall status: Not Yet Recruiting → Active, Not Recruiting
2026-08-14 NCT07344584
A Prospective Pilot Study to Evaluate Safety and Effectiveness of GP0122 and GP0124 for…
Trial sites expanded: 0 -> 5 locations
2026-08-14 NCT07344584
A Prospective Pilot Study to Evaluate Safety and Effectiveness of GP0122 and GP0124 for…
date change Primary completion pushed: 2027-04-30 -> 2027-05-30
2026-08-12 NCT06665477
Evaluate the Effectiveness and Safety of Restylane Volyme in the Treatment of Temple…
Trial completed
2026-07-28 NCT07074977
Proof of Concept Study to Assess the Pharmacokinetics/Pharmacodynamics of Nemolizumab in…
Enrollment closed, study ongoing
2026-07-28 NCT07074977
Proof of Concept Study to Assess the Pharmacokinetics/Pharmacodynamics of Nemolizumab in…
date change Primary completion pushed: 2026-09 -> 2026-12
New Trial Filings, Last 30 Days
First PostedTrialPhaseStatus
2026-08-13 NCT07762833 Randomized, Double-blind, Placebo-controlled Study of Nemolizumab in Chinese Subjects… Phase 3 Not Yet Recruiting
Active Trials by Phase
Phase 3
4
Phase 2
3
Not specified
8
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT07186413 A Study to Compare the Efficacy, Safety and Pharmacokinetics of Trifarotene 50 mcg/g… Acne Vulgaris Recruiting
NCT03989206 Long-term Safety and Efficacy of Nemolizumab With Moderate-to-severe Atopic Dermatitis Moderate-to-Severe Atopic Dermatitis Active, Not Recruiting
NCT04204616 A Long-term Study of Nemolizumab (CD14152) in Participants With Prurigo Nodularis (PN) Prurigo Nodularis Active, Not Recruiting
NCT07762833 Randomized, Double-blind, Placebo-controlled Study of Nemolizumab in Chinese Subjects… Atopic Dermatitis Not Yet Recruiting
Phase 2
NCT07047690 A Study of Nemolizumab for the Treatment of Adults With Systemic Sclerosis Systemic Sclerosis Recruiting
NCT07660835 Pharmacokinetics, Safety and Efficacy of Nemolizumab in Participants Aged 6 to 23 Months… Moderate-to-Severe Atopic Dermatitis Recruiting
NCT07074977 Proof of Concept Study to Assess the Pharmacokinetics/Pharmacodynamics of Nemolizumab in… Chronic Pruritus of Unknown Origin Active, Not Recruiting
Not specified
NCT07342400 A Clinical Study to Assess Histological Changes From Treatment of Poly L-lactic Acid… Cheek Wrinkles Recruiting
NCT07399028 A Study to Characterize Human Skin Changes From Biostimulator Treatments Via Non-invasive… Volume Deficiency in the Mid-Face Recruiting
NCT06988605 Real-world Experience Using Nemolizumab in the Treatment of Moderate-to-Severe Atopic… Atopic Dermatitis Recruiting
NCT06988618 Real-world Experience on Using Nemolizumab in the Treatment of Moderate-to- Severe… Prurigo Nodularis Recruiting
NCT07566286 Study to Evaluate the Safety of Retreatment With Restylane® Lyft With Lidocaine for… Chin Augmentation Recruiting
NCT05987163 Study to Evaluate the Safety and Effectiveness of GP0116 Skin Manifestations Active, Not Recruiting
NCT07047638 A Study to Evaluate the Effectiveness and Safety of Restylane Skinboosters Vital Lidocaine Skin Quality Improvement Active, Not Recruiting
NCT07344584 A Prospective Pilot Study to Evaluate Safety and Effectiveness of GP0122 and GP0124 for… Wrinkle Reduction Active, Not Recruiting
Disease Areas
Get alerts when Galderma R&D's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free